scholarly journals Study on the cause and pathogenesis of Alzheimer's disease

2019 ◽  
Author(s):  
zuodong sun

An enlightening viewpoint based on the theory of brain cell activation is to explore the pathogenesis and mechanism of sporadic Alzheimer's disease (AD) at molecular level by applying the principles of cell physics and biology. Its purpose is to coordinate and unify the existing theories of AD etiology and to solve the problems that have puzzled the research field of neurodegenerative diseases for a long time. Basic Contents: Excessive cations are transferred from extracellular to intracellular, and compete with potassium ions on the inner surface of the cell membrane. As a result, the action potential produced can not activate calcium channels normally, leading to abnormal apoptosis of brain cells. Amyloid plaques are the remains of abnormal apoptotic brain cells. Amyloid plaques are aggregated by van der Waals force and electrostatic attraction between amyloid plaques. The interstitium is amyloid protein. Brain cells consist of neurons, microglia and astrocytes in turn. Most of the spotted nuclei in the remains are cations. Applicable but not limited to neurodegenerative diseases such as Alzheimer's disease, physical means should be preferred to solve such diseases.

2020 ◽  
Vol 2020 ◽  
pp. 1-14
Author(s):  
Nesrine S. El Sayed ◽  
Mamdooh H. Ghoneum

Background. Many neurodegenerative diseases such as Alzheimer’s disease are associated with oxidative stress. Therefore, antioxidant therapy has been suggested for the prevention and treatment of neurodegenerative diseases. Objective. We investigated the ability of the antioxidant Antia to exert a protective effect against sporadic Alzheimer’s disease (SAD) induced in mice. Antia is a natural product that is extracted from the edible yamabushitake mushroom, the gotsukora and kothala himbutu plants, diosgenin (an extract from wild yam tubers), and amla (Indian gooseberry) after treatment with MRN-100. Methods. Single intracerebroventricular (ICV) injection of streptozotocin (STZ) (3 mg/kg) was used for induction of SAD in mice. Antia was injected intraperitoneally (i.p.) in 3 doses (25, 50, and 100 mg/kg/day) for 21 days. Neurobehavioral tests were conducted within 24 h after the last day of injection. Afterwards, mice were sacrificed and their hippocampi were rapidly excised, weighed, and homogenized to be used for measuring biochemical parameters. Results. Treatment with Antia significantly improved mice performance in the Morris water maze. In addition, biochemical analysis showed that Antia exerted a protective effect for several compounds, including GSH, MDA, NF-κB, IL-6, TNF-α, and amyloid β. Further studies with western blot showed the protective effect of Antia for the JAK2/STAT3 pathway. Conclusions. Antia exerts a significant protection against cognitive dysfunction induced by ICV-STZ injection. This effect is achieved through targeting of the amyloidogenic, inflammatory, and oxidative stress pathways. The JAK2/STAT3 pathway plays a protective role for neuroinflammatory and neurodegenerative diseases such as SAD.


2015 ◽  
Vol 11 (7S_Part_2) ◽  
pp. P86-P86
Author(s):  
Elena Rodriguez-Vieitez ◽  
Stephen F. Carter ◽  
Laure Saint-Aubert ◽  
Ove Almkvist ◽  
Karim Farid ◽  
...  

2019 ◽  
Author(s):  
zuodong sun

Objective: Alzheimer's disease (AD) has been reported for more than 100 years since its first discovery in 1906. There has been no significant progress in the study of its real causes and pathogenesis. The viewpoint of this paper is a heuristic viewpoint based on brain cell activation theory under such background. In this paper, the pathogenesis of sporadic AD is discussed at molecular level by applying the principles of cell physics and biology. The purpose of this paper is to harmonize the existing theories of etiology of AD and to solve the source problems that have plagued the research field of neurodegenerative diseases for a long time. Method: 1.Discuss the relationship with the existing hypothesis: the Aβ protein hypothesis, the tau protein hypothesis, the presenilin (PS) hypothesis, the apolipoprotein E (ApoE) hypothesis, the cholinergic hypothesis, the inflammatory hypothesis;2. Demonstration: biophysical proof, medical pathological proof, biological model proof; 3. Interpretation: ion channel and blood-brain barrier, potassium ion and potassium channel, ion pump and epilepsy and cancer, A beta protein and spots and plaques, related AD solutions. Result: 1. Abeta is not the cause of AD, but the late event of AD. 2. The K + concentration difference of 0.00001% which causes the great change of membrane potential is the effective concentration, which can not be neglected. 3. Abnormal impairment of potassium channels and early entry of sodium ions to occupy potassium positions are related to epilepsy, cancer and HeLa cells. 4. AD is a physical disease. especially transcranial magnetoelectricity stimulation, should be the first choice for treatment,which can activate abnormal neurons accurately without interfering with normal neurons. Conclusion: 1.Basic contents: excess cations are transferred from extracellular to intracellular. They compete position with potassium ions on the inner surface of cell membranes, thus abatementing the membrane potential, making action potential unable to activate calcium channels normally, which eventually leads to abnormal apoptosis of brain cells. Amyloid plaque are the remains of abnormal apoptotic brain cells. Amyloid plaque is the aggregation of amyloid spots by van der Waals force and electrostatic attraction, and its interstitium is amyloid protein.Brain cells consist of neurons, microglia and astrocytes in turn. Most of the spotted nuclei in the remains are cations. 2. Solutions: the core viewpoint of this paper can be regarded as exploring the etiology of sporadic AD, it is companion volume of Brain cell activation theory, Brain cell activation theory is an explanation of the treatment methods and mechanism of neurodegenerative diseases such as AD, it is suitable for encephalopathy but not limited to encephalopathy, the solution of AD should start with prevention and treatment, the external factor of prevention is environment, especially heavy metal ions, the internal cause is body acidity and alkalinity, physical means, especially transcranial magnetoelectricity stimulation, should be the first choice for treatment. 3. Naming principles: because of the core point of view in this paper—The position of cation occupying potassium is the initiating factor of AD, so the etiology theory is named Theory of dove-like particles. Take the Chinese idiom "Turtledove occupies the nest of magpies". "turtledove" represents the non-essential cation, "magpie" refers to the effective potassium ion, and "nest" refers to the position of the effective potassium ion.


2022 ◽  
Vol 23 (1) ◽  
pp. 548
Author(s):  
Jelena Osmanovic Barilar ◽  
Ana Knezovic ◽  
Jan Homolak ◽  
Ana Babic Perhoc ◽  
Melita Salkovic-Petrisic

The incretin system is an emerging new field that might provide valuable contributions to the research of both the pathophysiology and therapeutic strategies in the treatment of diabetes, obesity, and neurodegenerative disorders. This study aimed to explore the roles of central glucagon-like peptide-1 (GLP-1) and gastric inhibitory polypeptide (GIP) on cell metabolism and energy in the brain, as well as on the levels of these incretins, insulin, and glucose via inhibition of the central incretin receptors following intracerebroventricular administration of the respective antagonists in healthy rats and a streptozotocin-induced rat model of sporadic Alzheimer’s disease (sAD). Chemical ablation of the central GIP receptor (GIPR) or GLP-1 receptor (GLP-1R) in healthy and diseased animals indicated a region-dependent role of incretins in brain cell energy and metabolism and central incretin-dependent modulation of peripheral hormone secretion, markedly after GIPR inhibition, as well as a dysregulation of the GLP-1 system in experimental sAD.


2021 ◽  
pp. 11-18
Author(s):  
Andrew E. Budson ◽  
Maureen K. O’Connor

Alzheimer’s is a disease in which amyloid plaques build up in the brain. The plaques damage brain cells, the cells develop tangles, and the tangles destroy the cells. Alzheimer’s disease begins silently and progresses through very mild, mild, moderate, and severe stages. Age, being a woman, and family history are risk factors for the disease. Tests using a lumbar puncture or PET scan can help to confirm the diagnosis of Alzheimer’s disease, but they are only used in special circumstances. Lastly, you can reduce your risk of developing Alzheimer’s disease by eating a Mediterranean-style diet, engaging in aerobic exercise, and staying socially active.


2015 ◽  
Vol 11 (7S_Part_3) ◽  
pp. P127-P127
Author(s):  
Elena Rodriguez-Vieitez ◽  
Stephen F. Carter ◽  
Laure Saint-Aubert ◽  
Ove Almkvist ◽  
Karim Farid ◽  
...  

2010 ◽  
Vol 11 (2) ◽  
pp. 119-159
Author(s):  
Ivan Kramer

The series of mutations that cause brain cells to spontaneously and randomly die leading to Alzheimer's disease (AD) is modelled. The prevalence of AD as a function of age in males and females is calculated from two very different mutation models of brain cell death. Once the prevalence functions are determined, the number of people with AD in any country or city can be estimated.The models developed here depend on three independent parameters: the number of mutations necessary for a brain cell associated with AD to spontaneously die, the average time between mutations, and the fraction of the risk population that is immune to developing the disease, if any. The values of these parameters are determined by fitting the model's AD incidence function to the incidence data.The best fits to the incidence rate data predict that as much as 74.1% of males and 79.5% of females may benaturally immuneto developing AD. Thus, the development of AD isnot a normal or inevitableresult of the aging process. These fits also predict that males and females develop AD through different pathways, requiring a different number of mutations to cause the disease. The number of people in the USA with AD in the year 2000 is estimated to be 451,000.It is of paramount importance to determine the nature of the immunity to AD predicted here. Finding ways of blocking the mutations leading to the random, spontaneous death of memory brain cells would prevent AD from developing altogether.


2017 ◽  
Vol 133 (6) ◽  
pp. 933-954 ◽  
Author(s):  
Eleanor Drummond ◽  
Shruti Nayak ◽  
Arline Faustin ◽  
Geoffrey Pires ◽  
Richard A. Hickman ◽  
...  

Author(s):  
Andrew E. Budson ◽  
Maureen K. O’Connor

Alzheimer’s is a disease in which amyloid plaques build up in the brain. The plaques damage brain cells, the cells develop tangles, and the tangles destroy the cells. Alzheimer’s disease begins silently and progresses through very mild, mild, moderate, and severe stages. Age, being a woman, and family history are risk factors for the disease. Tests using a lumbar puncture or PET scan can help to confirm the diagnosis of Alzheimer’s disease, but they are only used in special circumstances. Lastly, you can reduce your risk of developing Alzheimer’s disease by eating a Mediterranean-style diet, engaging in aerobic exercise, and staying socially active.


Sign in / Sign up

Export Citation Format

Share Document